![Leif Gunnar Håkansson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Leif Gunnar Håkansson
Vorstandsvorsitzender bei CanImGuide Therapeutics AB
Profil
Leif Gunnar Håkansson is the founder of CanImGuide Therapeutics AB.
Prior to founding the company, he worked as the Head of Clinical Tumor Immunology Division at the University of Linköping and as an Associate Professor at the University of Lund.
He holds a doctorate degree from the University of Lund.
Aktive Positionen von Leif Gunnar Håkansson
Unternehmen | Position | Beginn |
---|---|---|
CanImGuide Therapeutics AB
![]() CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Leif Gunnar Håkansson
Unternehmen | Position | Ende |
---|---|---|
University of Linköping
![]() University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - |
University of Lund | Corporate Officer/Principal | - |
Ausbildung von Leif Gunnar Håkansson
University of Lund | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
CanImGuide Therapeutics AB
![]() CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |